Tag Archives: Corvia’s
Corvia’s RESPONDER-HF Confirmatory Trial Supported by RELIEVE-HF Recordsdata, Industry Recordsdata
Business new tamfitronics Second most important trial for atrial shunt treatment demonstrates significance of patient selection TEWKSBURY, Mass., April 12, 2024 /PRNewswire/ -- Corvia Clinical, Inc, a company dedicated to remodeling the treatment of coronary heart failure, welcomes the recent launch of V-Wave's RELIEVE-HF trial files supporting the evidence corrupt around atrial shunt treatment, which is currently below investigate cross-check in the global RESPONDER-HF trial of the Corvia®Atrial Shunt. RELIEVE-HF didn't fulfill its most important efficacy endpoint and didn't lower coronary heart failure events or toughen quality of lifestyles in coronary heart failure patients with a preserved ejection fragment (HFpEF). Nonetheless, the effects confirmed the importance of selecting patients...
